BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 2, 2021
View Archived Issues
MiR-30c mimics ameliorate liver fibrosis in vivo
Read More
Targeting tenascin-C could reduce the effects of retinal ischemia
Read More
FDA clears IND for investigational microbiome therapeutic SER-155
Read More
Immutep and Merck KGaA collaborate on phase I/II study of eftilagimod alpha plus bintrafusp alfa
Read More
Viracta initiates global pivotal study of nanatinostat plus valganciclovir in EBV+ lymphoma
Read More
Novel inhalable liposome formulations of antiviral drugs against COVID-19
Read More
Revolution Medicines discloses SOS1 inhibitors
Read More
Heptares Therapeutics patents GPR52 agonists
Read More
Dana-Farber Cancer Institute presents new PROTACs
Read More
Ventyx Biosciences synthesizes new TYK2 ligands
Read More
Valo Early Discovery identifies new HDAC8 inhibitors
Read More
NIH announces first-in-human study of FluMos-v1 universal influenza vaccine
Read More
Copeptin is a prognostic marker in schizophrenia spectrum disorder
Read More
Diverse cohort expands diabetes genomics
Read More
Transine Therapeutics secures funding to advance its novel class of therapeutic RNAs
Read More
Irisin and nucleobindin-2 predict cardiovascular risk in patients with NFAI
Read More
ATG3 gene is implicated in the development of NAFLD
Read More
N-803 shows safety and efficacy in combination with rituximab in iNHL
Read More
MCAD as novel therapeutic target for glioblastoma
Read More
